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Article Information  ABSTRACT 
Received: 18th March 2020  Corona virus disease is a kind of viral disease caused by Severe Acute Respiratory Syndrome- CoV 2, 
which is first witnessed in Wuhan city, China and it can be transmit from human to human. Coronavirus 
size ranges from (65-125 nm) in diameter and contain a single stranded RNA as nucleic acid material, 
size ranging from 26 to 32 kbps in length. The sub group of coronaviruses family is Alpha (α) Beta (β) 
Gama (γ) and delta (δ) coronavirus. Coronavirus disease is a kind of respiratory disease which mainly 
affects the lower respiratory tract of human body. Initially interferon α normalisation, broad spectrum 
antibiotic and antiviral drugs was used to reduce the viral load. There may be different kind of mode of 
transmission of this virus for example Respiratory transmission, Aerosol transmission, Contact 
transmission and Hospital acquired transmission. There is a well explained safety measures is provided 
to inhibit the COVID-19 spread which should be followed properly. There are some testing processes 
also developed to determine the presence of this virus. Till now not even a single vaccine is developed 
for the treatment of this COVID-19 but more than 12 countries across the globe are undergoing trial for 
more than 150 vaccine candidates. 
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INTRODUCTION 
Coronavirus disease was first emerged in china in a wet market 
where mainly all kind of meats were being sell [1].The infectious 
persons were associated with that wet market, the patients were 
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shopkeepers, vendors and market visitors. Wuhan city plays a 
major role in the outbreak of the infection and then finally the 
market was closed on January 1 2020 [2].The covid-19 
pandemic is due to SARS- CoV 2. Mortality rate due to covid-
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19 is found to be high among people over 60 years of age and 
who is already having some disease like hypertension, diabetes 
and cardiovascular disease. Till now there are mainly two types 
of cases are found in patient, one with major to minor symptom 
and one with completely no symptom, which are called 
asymptomatic [3]. The coronavirus identified as human 
pathogens since 1960. Coronavirus can infect human being as 
well as any other vertebrates. In human, mostly in the respiratory 
system gets affected and the symptoms range from cold to severe 
lower respiratory infection such as pneumonia. The main source 
of coronavirus is thought to be bat, which are also responsible 
for infections in human due to the intake of bat meat. There are 
different species of corona virus has been identified in bat [4]. 
From the discovery of this disease up to now, more than 7 lakh 
people in India got infected with this virus and the number of 
deaths has totalled of 20,653 July 7 at IST 11:50. Further WHO 
has shown that the mortality occurring due to COVID-19 was 
between 2-8 weeks. Thus, the number of death may be 
underestimated. The disease is comprises of mild to moderate 
symptoms, especially 85 % of the patients are found to have mild 
to moderate symptoms with a incubation period of 14 days. The 
seriousness of this disease also depends on the age of the patients 
also. One American survey revealed that elderly patients who 
are immune compromised, the mortality rate is high and again in 
infants or age group 0-6 years have a high mortality rate. 
Another article suggest that the patients who are having some 
auto immune disorder for example, Diabetes, Neuro 
degenerative disorder and Cancer they are more susceptible 
towards this infection and mortality is also high. Mortality 
related to the  disease may be as high as 60% in critically ill 
patients requiring hospital admission [5]. 
  
MATERIAL AND METHOD 
In this systematic review and analysis of this review article we 
searched Pubmed, Embassy, Researchgate and Sciencedirect 
and other web of scientific databases and articles published from 
December 31st to June 7, 2020, using the keywords 
“Coronavirus” “Safety measures of COVID-19 and “History and 
origin of COVID-19”. Considering the urgency of the topic and 
the need to increase the efficacy of the search and a grey 
literature survey is done on Google Scholar to capture all the 
updates. Databases mostly publish by the World Health 
Organization and other healthcare facilities were screened 
properly before making any information including all published 
and pre- proof databases. More information is being collected 
from the mentioned reference paper, published e- books, 
government safety posters and authentic news channels [6]. The 
literature search was restricted to articles issued in English. All 
the referred databases are authenticated and checked properly to 
avoid any sort of deception and made sure all the databases 
medRvix and bioRvix were reviewed [7]. 
 
CHARACTERISTICS OF CORONAVIRUS 
Coronavirus is a large linear, single stranded, positive strain, 
RNA genome and this positive genome can act as a messenger 
RNA (mRNA) [8]. The coronavirus is large virus and with a 
rough surface and particles with bulbous surface projection. The 
average size of the virus is about 125nm. The envelope of the 
virus is consisting of a lipid bi-layer in which membrane, 
envelope and spike structural proteins are encored (Wikipedia). 
The coronavirus surface spikes are homotrimers, which is 
composed of S1 and S2 sub unit. A homotrimeric  protein is a 
protein which is made up of three identical polypeptide units and 
which are responsible for binding the virus and the host cell [9]. 
There is a nucleoplasm inside the envelope, which is formed 
from multiple copies of the nucleoplasm (N) protein, which are 
bound to the single stranded positive RNA genome in 
continuous beads on a string type conformation. The lipid bi-
layer envelope, membrane proteins, and nucleoplasm protect the 
virus when it is outside the host cell. All coronaviruses contain 
specific genes on ORF1 downstream region that encode proteins 
for viral replication, nucleoplasm and spikes formation. The 
spike protein that is a conjugated protein in which the non-
protein group is carbohydrate are responsible for entering the 
virus in the host cells [10]. Other coronavirus mostly recognise 
amino peptidase or carbohydrates as a key receptor for entry to 
human cell while SARS-CoV and MARS-COV recognise exo 
peptidase. The inhaled virus SARS CoV 2 likely binds to 
epithelial cells in the nasal cavity and start replicating. In-vitro 
data with SARS-coV indicate that the ciliated cells are primary 
cells infected in the conducting airways. [6].  
 
At this stage the virus can be detected by nasal swab. The PCR 
technique may be useful for the determination of the viral 
infection in human body. Perhaps, super spreaders could be 
detected by these studies. In this RT-PCR technique it is 
important to have a count on the cycle number of virus life and 
incubation period and it is better to do nasal swab test will be 
much more accurate than the throat swab test. The virus (SARS 
CoV 2) propagates and migrates through the respiratory tract and 
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infects the lungs and blocks the airways as well as early markers 
of the innate immune response. As this time, the disease 
COVID-19 is clinically manifest. During this viral infection the 
cytokines level used to be high for example CXCL3 or the other 
cytokines. In viral infection the epithelial cells used to be filled 
with beta and lambda cells which are responsible for the 
blockage of the airways or the upper respiratory tract which 
ultimately lead to difficulty in breathing. These patients can be 
monitored in home with conservative therapy [11].  
 
MODE OF TRANSMISSION OF CORONA VIRUS  
1. Respiratory transmission: According to Centre of Disease 
Control and Prevention (CDC) the pandemic COVID-19 is 
mainly spread through respiratory droplets specially while 
sneezing, coughing and while speaking loud with someone 
when they are carrying viruses. One more important factor 
is that those people who are spreading virus 25% of them 
may be asymptomatic [12]. 
2. Aerosol transmission- This is an important source of 
transmission. Other than coughing, sneezing and talking the 
aerosol transmission also plays an important role is 
spreading the virus. This is mainly spread through droplets 
in case of spitting by infected person or the mucus of that 
person. People emits droplets in different shapes and sizes 
and which are small enough to be considered as aerosol and 
which can suspended in air for hours and can travel in air 
for 10 feet but depending on the size of the droplets the 
distance may vary. 
 
Other possible mode of transmission- 
1. Formite spread- Formite spread is also known as a 
secondary mode of transmission of SARS CoV 2. This is a 
mode of transmission in which the virus is transmitted when 
a healthy person touches a surface or any object where the 
virus is already present due to touching or sitting by the 
already infected person. But not proper validation has been 
found in this mode of this transmission so proper studies 
need to be performed to proof this mode of transmission 
[13]. 
2. Hospital acquired infection- In this mode of transmission 
the virus is transmitted in doctors, nurses and other 
healthcare professionals when they are associated with the 
treatment of COVID-19 patients. This is an important mode 
of transmission as it is associated with the front liners in this 
pandemic [13]. 
Recently, WHO declared that covid 19 is found to be air born 
though it is not well established fact. More studies and 
experiment should be performed for establishing the data. 
 
SAFETY MEASURES OF COVID-19 
• Lockdown of infected areas  
• Travel restrictions 
• Continuous surveillance and active contact tracing 
• Quarantine of close contacts is essential, as they may not 
have symptoms initially but may develop symptoms later as 
the incubation period of the virus varies from 5-14 days 
• To wear a face mask on a mandatory basis  
• Proper measures should be taken by the governments by 
providing sufficient PPE (personal protective equipments 
for the health workers. 
1. Personal level protection  
We should cover our face with clothes while sneezing and 
coughing, one should maintain at least 6ft distance with each 
other while they are staying outside of their house and we should 
wear mask before we go out from home.  
 
2. Staying at home 
 According to WHO, still now there is no vaccine for corona 
virus, nor any medications that can treat corona virus. So the best 
way to avoid this infection is to stay at home and eliminate 
contacts with individuals who have any kind of travel history.  
 
3. Washing hand:- 
          It is recommended to wash our hand as frequent as 
possible with soap and water by following WHO guidelines for 
washing hand. Hand should be sanitized with the alcohol based 
sanitizer whenever there is no access to soap and water. 
 
4. Disinfect surfaces:- 
 Keeping you germ free wouldn’t be effective if the 
surrounding is not germ free. Cleaning floors, door, windows, 
and courtyard is very essential. Any type of disinfected can be 
used for this case. 
 
5. Monitoring our health: 
           We should monitor our health as frequently as possible 
like temperature or any symptoms of flu like runny nose, cough, 
cold, shortness of breath or any other symptoms like fatigue, 
muscle or body aches, headache, sore throat, nausea and 
vomiting. 
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           We should not ignore or hide any of the symptoms from 
the health professionals. If any kind of medical emergency 
happens immediately seek medical help. 
 
6. Boosting immunity: 
According to some American news channel if our immunity is 
strong enough then we are less    susceptible to get infection and 
if we still got that means we can speedy recovery. 
           For boosting immunity we can take vitamin rich fruits for 
example Gooseberry, Lemon, Orange, and also can take vitamin 
C supplements. 
           Exercise is also a great way to boost our immunity and 
pump up our lungs [14]. 
 
SYMPTOMS OF SARS CoV 2 
COVID-19 virus infects different people in different person in 
different way. Most of the infected people will develop 
symptoms from mild to moderate symptoms and which can be 
cured without hospitalization. 
Most common symptoms- 
Fever 
Dry cough 
Tiredness 
Less common symptoms 
Aches and pains 
Sore throat 
Diarrhoea 
Headache 
Loss of taste or smell 
Rashes on skin and limb discoloration 
Serious symptoms- 
Difficulty in breathing and shortness of breath 
Chest pain or pressure 
Loss of speech or movement [14] 
 
* Asymptomatic SARS CoV 2 patients 
          Previously it was thought that the virus is can be transmit 
through the patients those who are showing symptoms in terms 
of coughing, sneezing or touching but recent articles have been 
shown that the corona virus disease can be spread through the 
silent spreaders also. The silent spreaders are those who do not 
develop any kind of symptoms or sometimes mild symptoms but 
they infect other patients as the virus is already present in their 
body. These silent spreaders are found to be mostly children and 
young people who are having strong immunity. It is also found 
that one can test positive for covid 19 tests without showing mild 
or no symptoms when they are coming in contact with a 
COVID19 patients. Depending upon the symptoms we cannot 
classify CIOVID19 patients but broadly they can classified as 
• Patients with mild to moderate symptoms 
• Patients with completely no symptoms 
• Pre- symptomatic 
• Patients with moderate to serious symptoms 
• Patients who are having multiple organ dysfunction 
[15]. 
 
TEST FOR CORONAVIRUS DISEASE 
Real time PCR technique: Real Time PCR technique is 
different from conventional PCR technique which is more 
sensitive and accurate than the conventional. The real time PCR 
technique is used for the determination of SARS-CoV 2 in the 
faces of bats as bats were known as primary reservoir of this 
virus. The technique is mostly used in molecular biology to 
amplify the desire DNA. This technique is based on the 
utilization of the DNA polymerase which is an in vitro 
replication of specific DNA. This test is performed by collecting 
blood sample or respiratory fluid with the help of a swab the 
respiratory fluid is collected. The fluid is collected from the 
nasopharyngeal junction which is done through a narrow stick 
made of a short plastic rubber that is covered, at one tip, with 
absorbing material such as sterile Dacron or rayon ensuring viral 
transport media. The results of this test can be found out within 
few hours of the test. The sample is mainly collected within 48 
hours interval both nasopharyngeal and blood samples for better 
accuracy in result [16]. 
 
Viral sequencing: - The viral sequencing can be done through 
High- throughput sequencing (HTS) and whole- genome 
sequencing (WGS) technologies. Monitoring of the viral 
genomic mutation is important to have better of medical counter 
measures.  So it recommended that sequencing of this virus in a 
regular basis is important to know the gene mutation or the 
changes in the sequencing [17]. 
 
ELISA technique: - The standard test is ELISA (enzyme linked 
immunosorbent assay). Two types of antibodies are tested i.e. 
IgM antibody which rises first after infection and it is an 
indicator for an active infection and the other one is IgG type of 
antibody rises later and it is an indication of past infection. This 
test is useful for the rapid determination of the spreaders may be 
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with mild to moderate symptom or moderate to high symptoms 
or with completely no symptoms.  [18].  
 
Bronchial fibroscopy: - Bronchial fibroscopy is an endoscopic 
technique in which the bronchoscope is inserted through the 
nasal cavity or mouth and sometimes trachea. It is a useful 
procedure to determine any kind of infection in lungs or 
bronchiole. Because if any type infection is there in lungs than 
the alveoli will be full of interferon. Basically this test will 
determine the amount of interferon present in the alveoli. 
 Pulmonary function tests (PFTS): - Pulmonary function test 
is an encroaching technique in which the proper functioning of 
the lungs is been tested. If any kind of viral infection is there 
than the airways of the patient may be blocked and the patient 
may suffer from difficulty in breathing  [19]. 
 
CONCLUSION AND PERSPECTIVE 
 The SARS CoV 2 viruses are spreading rapidly worldwide as a 
global threat. It is very important for the human beings to adapt 
all the necessary precaution provided by the WHO (World 
Health Organization). This pandemic also affected the economy 
and business market across the globe. Though SARS CoV 2 is a 
respiratory disease, recent studies also shows that it can develop 
infection in the other parts of our body for example heart, kidney 
and liver. It is also found that encephalopathy, inflammation in 
CNS and Guillian Barre is prevalence in COVID-19 patients 
[20]. Until now no promising vaccine was found for coronavirus. 
However Glenmark first Pharma firm to get approval for an oral 
drug to treat COVID-19 patients in India [21].  Recently Drug 
Controller General of India (DCGI) informed that a company 
name Glenmark recently launch its first drug for COVID-19 
with a brand name fabiflu, which is claimed to be effective in 
patients who are having a mild to moderate symptoms  [22] [23].  
 
The possible mechanism of action of this drug is that it inhibits 
the DNA replication in cellular level and stops the rapid growth 
of the virus. Till today not even a single vaccine is developed for 
the treatment for the treatment of COVID-19. Worldwide more 
than 12 countries are going through clinical trials for more than 
150 vaccine candidate to combat the global pandemic  [24].    
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